Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP
NCT ID: NCT00508729
Last Updated: 2007-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
300 participants
INTERVENTIONAL
2007-10-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qingyi granules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Complying with the diagnostic standard of acute pancretitis (clinical symptoms and signs, elevated blood and urine amylase, and imaging criteria)
* Conforming to 3 or more Ranson's criteria and APACHE-II score larger than 8, Balhazar CT score larger than 5
Exclusion Criteria
* Nursing mother
* Critical cases of advanced tumor
* On the verge of death (estimated to be moral in 12h)
* Severe visceral function disturbance
* Patients undergoing other therapeutic research that might interfere with the present study
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College
OTHER
Tianjin Nankai Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Naiqiang Cui, Dr
Role: PRINCIPAL_INVESTIGATOR
Tianjin Nankai Hospital
Zhuming Jiang, Dr
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Guangdong Medical College
Zhanjiang, Guangdong, China
Guizhou Province People's Hospital
Guiyang, Guizhou, China
The 1st Affiliated Hospital, Dalian Medical Unversity
Dalian, Liaoning, China
West China Hospital, Sichuan Unversity
Chengdu, Sichuan, China
Zhejiang Province People's Hospital
Hangzhou, Zhejiang, China
Zhejiang Province Traditional Chinese Medicine Hospital
Hangzhou, Zhejiang, China
Dongzhimen Hospital of Beijing Traditional Chinese Medicine University
Beijing, , China
Peking Union Medical College Hospital
Beijing, , China
Longhua Hospital of Shanghai Traditional Chinese Medicine Unversity
Shanghai, , China
Tianjin Nankai Hospital
Tianjin, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Huilai Miao, Dr
Role: primary
Chengxian Shi, Dr
Role: primary
Zaiyuang Ye, Dr
Role: primary
Qin Zhang, Dr
Role: primary
Naiqing Li, Dr
Role: primary
JIngzhe Zhang, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006BAI04A15-1
Identifier Type: -
Identifier Source: org_study_id